GoLiver Therapeutics
GoLiver Therapeutics is specialized in the development of Innovative Therapy Medicines to meet an unmet urgent medical.
GoLiver Therapeutics is a business in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
Its activity falls under biotechnology; the profile below is assembled from public directory data.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Grant stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $1M.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $1,000,000 |
Website: golivertx.com
Browse related
Sign in to view the contact information we hold for GoLiver Therapeutics.
Create a free account
Create a free account